Mergers & Acquisitions - Generics, Financial


Current filters:


Popular Filters

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending


With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s


Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal


Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

AMRI to acquire Cedarburg Pharmaceuticals in $41 million deal


Albany Molecular Research, a USA-based contract research and manufacturing organization, has signed a…

Albany Molecular ResearchCedarburg PharmaFinancialGenericsMergers & Acquisitions

Stada Arz buys UK OTC manufacturer


German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram


US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

Hikma to retain its global Injectables business


Further to its announcement last month that it was undertaking a review of the strategic options for…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Hikma leaps as it confirms unsolicited interest in Injectables business


Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday,…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Pernix splashes out over $100 million to buy Cypress Pharma and Hawthorn Pharma


US specialty drugmaker Pernix Therapeutics (NYSE: PTX) has entered into a definitive agreement to acquire…

Cypress PharmaceuticalsFinancialGenericsHawthorn PharmaceuticalsMergers & AcquisitionsPernix TherapeuticsPharmaceutical

Fitch puts Watson on rating watch Negative on planned acquisition of Actavis


US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has seen its rating downgraded by Fitch Ratings,…

ActavisFinancialGenericsMergers & AcquisitionsNorth AmericaWatson Pharmaceuticals

Valeant Pharma to acquire assets in Mexico; Mylan invests in Ireland


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

Atlantis PharmaEuropeFinancialGenericsMergers & AcquisitionsMylan LaboratoriesSouth AmericaValeant Pharmaceuticals

Flamel Tech acquires US firm Eclat Pharma; reports loss


Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

Back to top